Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-094563
Filing Date
2009-04-30
Accepted
2009-04-30 16:49:02
Documents
6
Period of Report
2009-06-25
Effectiveness Date
2009-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 610819
2 GRAPHIC g62758g32i93.jpg GRAPHIC 3660
3 GRAPHIC g62758g64f28.jpg GRAPHIC 10463
4 GRAPHIC g62758g91u93.jpg GRAPHIC 149273
5 GRAPHIC g62758g94c52.jpg GRAPHIC 6387
6 GRAPHIC g62758g96q80.jpg GRAPHIC 255464
  Complete submission text file 0001193125-09-094563.txt   1199097
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 09784549
SIC: 2835 In Vitro & In Vivo Diagnostic Substances